| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2330929 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 100 uM oxaliplatin (Rvb = 52.2 +/- 0.5%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA2330930 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 30 uM oxaliplatin (Rvb = 81.9 +/- 0.9%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA2330931 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 10 uM oxaliplatin (Rvb = 87.2 +/- 0.9%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 4. | ALA2330932 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 3 uM oxaliplatin (Rvb = 92.3 +/- 1.0%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA2330933 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 1 uM oxaliplatin (Rvb = 94.9 +/- 1.3%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 6. | ALA2330934 | F | Antiapoptotic activity against human HT-29 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay in presence of 0.3 uM oxaliplatin (Rvb = 97.6 +/- 0.9%) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA2330935 | F | Antiapoptotic activity against Sprague-Dawley rat astrocytes assessed as reduction of oxaliplatin-induced caspase-3 activity at 1 uM after 4 hrs by fluorimetric assay | Rattus norvegicus | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA2330936 | F | Antiapoptotic activity against Sprague-Dawley rat astrocytes assessed as reduction of oxaliplatin-induced caspase-3 activity at 0.1 to 10 uM after 4 hrs by fluorimetric assay | Rattus norvegicus | 4 | cell-based format | Scientific Literature | ||
| 9. | ALA2330937 | B | Inhibition of human A2B adenosine receptor transfected in CHO cells assessed as inhibition of NECA-induced cyclic AMP production at 1 uM after 10 mins by competitive protein binding assay | Homo sapiens | 33 | cell-based format | Scientific Literature | ||
| 10. | ALA2330938 | F | Inhibition of human A3 adenosine receptor transfected in CHO cells assessed as inhibition of forskolin-induced cyclic AMP production after 10 mins by competitive protein binding assay in presence of CI-IB-MECA | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 11. | ALA2330941 | B | Displacement of [3H]ZM241385 from human A2A adenosine receptor expressed in CHO cells at 1 uM after 60 mins by scintillation counting analysis | Homo sapiens | 34 | cell-based format | Scientific Literature | ||
| 12. | ALA2330942 | B | Displacement of [3H]DPCPX from human A1 adenosine receptor expressed in CHO cells at 1 uM after 120 mins by scintillation counting analysis | Homo sapiens | 33 | cell-based format | Scientific Literature | ||
| 13. | ALA2330943 | B | Displacement of [125I]AB-MECA from rat A3 adenosine receptor expressed in HEK293 cells at 1 uM after 60 mins by scintillation counting analysis | Rattus norvegicus | 4 | cell-based format | Scientific Literature | ||
| 14. | ALA2330944 | B | Displacement of [125I]AB-MECA from human A3 adenosine receptor expressed in CHO cells after 60 mins by scintillation counting analysis | Homo sapiens | 27 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!